60 Degrees Pharmaceuticals I
13F holders, Q3 2025 (September 30)7holders +2
2new positions
0sold out
$1.48avg. 13F price*
At the end of Q3 2025, 7 institutions reported holding 60 Degrees Pharmaceuticals I in their 13F filings, up 2 from Q2 2025. 2 opened new positions and 0 sold out. The largest holders were DRW Securities, LLC ($37K), Geode Capital Management, LLC ($18K) and Tower Research Capital LLC (TRC) ($5K).
- Company
- 60 Degrees Pharmaceuticals I
- CUSIP
- 83006G401
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $38K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 27,421 shares bought and 67 shares sold, net +27,354 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| DRW Securities, LLC | 0.00% | New | 25,211 | $37K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.5% | 12,449 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +20.9% | 3,140 | $5K |
| UBS Group AG | 0.00% | Add +10442.9% | 1,476 | $2K |
| Citigroup Inc. | 0.00% | New | 189 | $278 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $141 |
| Bank of America Corp. | 0.00% | Add +130.8% | 30 | $44 |
"% of holder's portfolio" is 60 DEGREES PHARMACEUTICALS I's weight in each manager's 13F, not the share of 60 Degrees Pharmaceuticals I the manager owns.